Personal CGM

Dexcom G5 Mobile

You are here

Dexcom G5® Mobile Continuous Glucose Monitoring (CGM) System

Dexcom offers patients a diabetes care management solution that offers lifestyle freedom and flexibility in the day-to-day management of their diabetes. The Dexcom G5 Mobile was the first CGM system FDA-approved as a replacement to fingersticks for use in making diabetes treatment decisions, including dosing.*

Important Safety Information

*Fingersticks required for calibration, or if symptoms or expectations do not match readings, or when taking medications containing acetaminophen.

#1 Patient Preferred CGM System 7 Years in a Row!<sup>1</sup>

Personal CGM

Exceptional Accuracy

With exceptional glucose accuracy compared with the reference laboratory gold standard, Dexcom CGM instills the confidence patients need to proactively manage their diabetes.2


Fully Mobile System

The Dexcom G5 Mobile CGM System offers your patients lifestyle flexibility and convenience, allowing them to easily view and share their glucose data right from their smart devices.

Approved for Dosing

The Dexcom G5 Mobile CGM System is the first FDA-approved CGM system for use in making diabetes treatment decisions.* Your patients can confidently manage their diabetes throughout the day with fewer fingersticks.


Glucose Analysis

With Dexcom CLARITY® software, get clinically relevant insights in minutes. With this web-based software, you can quickly assess the quality of your patient's glycemic control, evaluate risk for hypoglycemia, and identify glucose patterns.

*Fingersticks required for calibration, or if symptoms or expectations do not match readings, or when taking medications containing acetaminophen. 

24/7 Monitoring

Readings are updated every 5 minutes, giving patients get real-time feedback and insights about their glucose levels day and night.

Pattern Reports

Dive deeper into patient high and low events in the pattern reports.

A Closer Look at the Dexcom G5 Mobile

The Dexcom G5 Mobile requires a prescription and is indicated for pediatric and adult patients ages 2 years and older. The System contains 3 components:

  1. The sensor - a small sensor wire inserted just underneath the skin picks up electrochemical signals from glucose oxidase reactions in the interstitial fluid and sends them to the transmitter.
  2. The transmitter - Bluetooth® technology housed in the transmitter sends glucose data wirelessly to the display device.
  3. Display device - Glucose data and trends are displayed either on the Dexcom G5 Mobile receiver or a compatible smart device.

Optimize Patient Therapy

When your patient is just starting on insulin therapy or you are initiating a regimen change, determining the optimal regimen can be a challenge due to many unknown variables, including a patient's unique physiology, lifestyle choices and behaviors. Dexcom CGM use can help with day-to-day management for your patient in the following ways:

  • Real-time glucose readings and trend information can be used to make diabetes treatment decisions.*
  • Built-in hypo alarms and alerts warn of impending lows and highs, allowing patients to make diabetes treatment decisions* to course correct.
  • Patients can enter events into the Dexcom G5 Mobile receiver or their compatible smart device,‡ enabling them to see the impact of exercise, meals and other daily events.

*Fingersticks required for calibration, or if symptoms or expectations do not match readings, or when taking medications containing acetaminophen. 

For a list of compatible devices, please visit dexcom.com/compatibility. Dexcom receiver is part of the system; smart device sold separately.

±The Dexcom Follow App is not included as part of the Dexcom G5 Mobile CGM System. Followers must download the Dexcom Follow App separately. Internet connectivity required to access Dexcom Follow. Followers should always confirm readings on the Dexcom G5 Mobile App or Receiver before making treatment decisions.

1dQ&A market research study. 2009-2015

2Pettus J, Price DA, Edelman SV. How Patients with Type 1 Diabetes Translate Continuous Glucose Monitoring Data into Diabetes Management Decisions. Endocr Pract. 2015;:1-25.

Medicare Coverage for Therapeutic CGM

Contact Dexcom

If you are a clinician and want to learn more about Dexcom’s Continuous Glucose Monitoring Systems, please fill out the form and a Dexcom representative will contact you.

If you are a Dexcom User or Patient, please contact Dexcom here.

The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.